Methylene blue ameliorates colonic injury in acetic acid-induced colitis model

Basit Öğe Kaydı
dc.authorid0000-0003-0889-9586
dc.contributor.authorTanrıkulu, Yusuf
dc.contributor.authorŞen Tanrıkulu, Ceren
dc.contributor.authorKılınç, Fahriye
dc.contributor.authorCan, Murat
dc.contributor.authorKöktürk, Fürüzan
dc.contributor.authorKargın, Süleyman
dc.contributor.authorYılmaz, Gökhan
dc.date.accessioned2023-03-06T11:24:23Z
dc.date.available2023-03-06T11:24:23Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalı
dc.description.abstractAim: Inflammatory bowel disease (IBD) is a serious health problem affecting the quality of life. IBDs caused by various pathophysiological mechanisms, including genetic, immunological, inflammatory, and environmental factors. Although it has been widely investigated, treatment of IBDs remains a difficult clinical problem. We aimed to investigate the healing of mucosal damage and anti-inflammatory effects of methylene blue (MB) in experimental colitis model. Material and Methods: Twenty-eight rats were randomly divided into four equal groups: group 1 (Sham), group 2 (control), group 3 (topical treatment), and group 4 (topical and systemic treatment). In groups 2, 3, and 4, acetic acid-induced colitis model was created. Normal saline to group 2, topical MB to group 3, and topical and systemic MB to group 4 were given. Results: The levels of hydroxyproline were lower in the treatment groups than in the control group (p=0.017 for group 3 and p=0.004 for group 4). There was no difference between groups according to the TNF- alpha levels. The results of macroscopic scores were significantly lower in treatment groups (group 3-4) than In the control group (group 2) (p=0.005 for group 3 and p=0.002 for group 4). There was a significant difference between the treatment groups and the control group according to the epithelial loss and inflammatory infiltrate (p=0.022 for group 3, p=0.026 for group 4 for both histopathological values). Discussion: MB ameliorates colonic injury in acetic acid-induced colitis model This effect of MB was observed both locally and with local + systemic administration.
dc.identifier.citationTanrıkulu, Y., Şen Tanrıkulu, C., Kılınç, F., Can, M., Köktürk, F., Kargın, S. ... Yılmaz, G. (2022). Methylene blue ameliorates colonic injury in acetic acid-induced colitis model. Annals of Clinical and Analytical Medicine, 13(2), 146-150. https://dx.doi.org/10.4328/ACAM.20889
dc.identifier.doi10.4328/ACAM.20889
dc.identifier.endpage150
dc.identifier.issn2667-663X
dc.identifier.issue2
dc.identifier.startpage146
dc.identifier.urihttps://dx.doi.org/10.4328/ACAM.20889
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10573
dc.identifier.volume13
dc.identifier.wos000729280800001en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthorYılmaz, Gökhan
dc.language.isoen
dc.publisherBayrakol Medical Publisher
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcetic Acid
dc.subjectColitis
dc.subjectInflammatory Bowel Disease
dc.subjectMethylene Blue
dc.subjectTNF-?
dc.titleMethylene blue ameliorates colonic injury in acetic acid-induced colitis model
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Yılmaz-Gokhan-2022.pdf
Boyut:
286.05 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu